Verrica Pharmaceuticals Inc (VRCA)
0.9945
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
1.00
+0.01
(+0.55%)
After-Hours: 20:00
Verrica Pharmaceuticals Shares Outstanding: 45.60M for Oct. 28, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 28, 2024 | 45.60M |
September 30, 2024 | 45.60M |
August 08, 2024 | 42.67M |
June 30, 2024 | 42.46M |
May 07, 2024 | 42.42M |
April 12, 2024 | 42.42M |
March 31, 2024 | 42.42M |
February 23, 2024 | 42.42M |
December 31, 2023 | 42.41M |
November 03, 2023 | 42.06M |
September 30, 2023 | 42.06M |
August 01, 2023 | 42.06M |
June 30, 2023 | 41.85M |
May 03, 2023 | 41.85M |
April 14, 2023 | 41.85M |
March 31, 2023 | 41.85M |
March 01, 2023 | 41.85M |
February 23, 2023 | 41.84M |
December 31, 2022 | 41.09M |
November 02, 2022 | 41.09M |
September 30, 2022 | 41.09M |
August 05, 2022 | 41.09M |
July 08, 2022 | 41.09M |
July 05, 2022 | 39.52M |
June 30, 2022 | 27.52M |
Date | Value |
---|---|
May 02, 2022 | 27.52M |
April 14, 2022 | 27.52M |
March 31, 2022 | 27.52M |
February 24, 2022 | 27.52M |
December 31, 2021 | 27.52M |
November 04, 2021 | 27.52M |
September 30, 2021 | 27.52M |
August 02, 2021 | 27.51M |
June 30, 2021 | 27.51M |
May 03, 2021 | 27.41M |
April 16, 2021 | 27.51M |
March 31, 2021 | 27.49M |
March 25, 2021 | 27.48M |
March 15, 2021 | 25.44M |
December 31, 2020 | 25.44M |
November 05, 2020 | 25.87M |
September 30, 2020 | 25.87M |
July 30, 2020 | 25.81M |
June 30, 2020 | 25.81M |
May 04, 2020 | 25.81M |
April 15, 2020 | 25.81M |
March 31, 2020 | 25.81M |
March 06, 2020 | 25.81M |
December 31, 2019 | 25.79M |
November 01, 2019 | 25.78M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
25.44M
Minimum
Dec 31 2020
45.60M
Maximum
Sep 30 2024
34.27M
Average
27.52M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Biomarin Pharmaceutical Inc | 190.58M |
Elite Pharmaceuticals Inc | 1.068B |
Eagle Pharmaceuticals Inc | 12.99M |
TELA Bio Inc | 39.39M |
Terns Pharmaceuticals Inc | 84.94M |